+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Left Atrial Appendage Closure Device Market - Global Forecast 2026-2032- Product Image
Left Atrial Appendage Closure Device Market - Global Forecast 2026-2032- Product Image
Sale

Left Atrial Appendage Closure Device Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904983
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Left Atrial Appendage Closure Device Market is projected to reach USD 1.04 Billion in 2026. It is expected to continue growing at a CAGR of 9.35%, reaching USD 1.78 Billion by 2032.

The left atrial appendage closure device market is anchored in the clinical burden of atrial fibrillation, a rhythm disorder associated with an approximately fivefold increase in ischemic stroke risk. Global Burden of Disease analyses estimate tens of millions of people live with atrial fibrillation worldwide, while public health agencies in major economies report rising prevalence as populations age and cardiovascular risk factors persist.

Left atrial appendage occlusion addresses a defined need in nonvalvular atrial fibrillation: reducing thromboembolic risk when long-term oral anticoagulation is unsuitable or carries unacceptable bleeding risk. Evidence from randomized trials, post-approval studies, and real-world registries has positioned percutaneous LAA closure as a guideline-recognized option for selected patients, creating durable demand for safer implants, improved delivery systems, advanced imaging support, and standardized post-procedure antithrombotic care pathways.

Transformative Shifts in the LAA Closure Landscape

The competitive landscape is shifting from early device adoption toward evidence-led, workflow-integrated structural heart programs. FDA-approved and internationally authorized LAA closure platforms, together with expanding use of occluder technologies across developed and emerging health systems, have moved left atrial appendage closure from a niche intervention to an established procedure within electrophysiology and interventional cardiology.

Key market shifts include broader referral from anticoagulation clinics, greater use of transesophageal echocardiography, computed tomography, and intracardiac echocardiography, and hospital focus on reducing ischemic stroke and major bleeding events in high-risk atrial fibrillation populations. Device selection is increasingly shaped by seal performance, device conformability, recapture capability, procedural efficiency, residual leak reduction, device-related thrombus monitoring, and the strength of outcomes data rather than device access alone.

Cumulative Impact of Artificial Intelligence on LAA Closure

Artificial intelligence is increasingly cumulative rather than disruptive in isolation: its value builds across patient identification, imaging, procedure planning, and longitudinal surveillance. AI-enabled analytics can help screen electronic health records for atrial fibrillation patients with elevated CHA2DS2-VASc scores, high HAS-BLED scores, prior bleeding, renal dysfunction, recurrent falls, or anticoagulant intolerance, improving referral precision for LAA occlusion evaluation.

In imaging, AI-assisted segmentation of the left atrial appendage may support sizing, morphology classification, landing-zone assessment, and peri-device leak-risk evaluation. Over time, machine learning models trained on registry and hospital data can refine predictions for device-related thrombus, peri-device leak, readmission, procedural complications, and antithrombotic regimen selection, provided algorithms are clinically validated, monitored for bias, and governed under medical device software regulations.

Key Regional Insights Across Major LAA Closure Markets

North America remains a leading region because of cleared left atrial appendage closure devices, mature structural heart programs, established reimbursement pathways, and large real-world atrial fibrillation registries. Europe shows strong clinical adoption through experienced electrophysiology centers, CE-marked technologies, and guideline-driven stroke prevention strategies, although reimbursement, hospital procurement, and health technology assessment requirements vary across national systems.

Asia-Pacific is expanding as Japan, China, South Korea, Australia, and India respond to aging populations, rising cardiovascular disease burden, and increasing diagnosis of atrial fibrillation. Latin America is progressing through private hospitals and tertiary cardiac centers, led by countries with established interventional cardiology infrastructure. The Middle East is advancing through investment in specialized cardiac services, particularly in high-income health systems, while Africa remains earlier in adoption, with access shaped by specialist availability, imaging infrastructure, procurement capacity, and wider recognition of LAA closure for patients at high bleeding risk who cannot remain on anticoagulation.

Key Group Insights for LAA Closure Adoption

Within the European Union, harmonized medical device regulation and large cardiovascular networks support evidence generation for LAA closure devices, but country-level reimbursement determines adoption speed. G7 health systems benefit from advanced imaging, experienced interventional teams, strong payer scrutiny, and established atrial fibrillation care pathways, making comparative clinical outcomes, safety data, and health economic evidence central to device selection.

BRICS countries offer significant long-term clinical relevance due to large atrial fibrillation populations and expanding cardiovascular care capacity, yet access depends on affordability, local regulatory approvals, physician training, and hospital infrastructure. ASEAN markets are developing through private tertiary care, medical tourism hubs, and growing electrophysiology services, while GCC countries are investing in specialized cardiac programs and advanced stroke prevention. NATO membership does not directly determine healthcare adoption, but many NATO countries overlap with high-income systems that fund structural heart intervention and advanced atrial fibrillation management technologies.

Key Country Insights Shaping LAA Closure Demand

The United States leads commercialization through cleared LAA occlusion devices, national registry participation, and 2023 atrial fibrillation guidelines that support percutaneous LAAO for selected patients with contraindications to long-term anticoagulation or high bleeding risk. Canada follows evidence-based adoption through provincial reimbursement review and specialist cardiac centers, while Mexico and Brazil are expanding mainly through private and tertiary cardiovascular hospitals with growing structural heart expertise.

The United Kingdom, Germany, France, Italy, and Spain have experienced structural heart and electrophysiology programs, though reimbursement policies, procurement processes, and waiting-list pressures shape procedure access. Germany and France benefit from strong hospital-based cardiovascular networks, while the United Kingdom emphasizes guideline-based evaluation and health system prioritization. Italy and Spain show adoption through regional centers with established imaging and interventional capacity, and Russia’s adoption is influenced by procurement access, specialist concentration, and broader cardiovascular policy conditions.

China and India represent high-potential clinical settings due to population scale, increasing atrial fibrillation diagnosis, and expansion of tertiary cardiac care, though affordability and physician training remain important access factors. Japan, South Korea, and Australia combine aging demographics with strong specialist capacity, advanced imaging availability, and structured regulatory oversight, supporting evidence-based use of left atrial appendage closure for carefully selected nonvalvular atrial fibrillation patients.

Actionable Recommendations for LAA Closure Industry Leaders

Industry leaders should prioritize clinical evidence, physician education, and patient-selection tools that align with current atrial fibrillation guidelines. The strongest commercial strategies will integrate LAA closure into multidisciplinary stroke prevention pathways involving electrophysiologists, interventional cardiologists, neurologists, imaging specialists, anticoagulation clinics, and shared decision-making programs for patients at elevated bleeding risk.

Manufacturers should invest in real-world evidence, AI-enabled imaging support, post-market surveillance, and device designs that reduce procedure time, residual leak risk, and device-related thrombus concerns. Market access teams should develop country-specific economic dossiers demonstrating avoided ischemic stroke, reduced long-term bleeding exposure, lower anticoagulation management burden, and value for high-risk patients who are poor candidates for lifelong anticoagulation.

Research Methodology for Evidence-Based Market Analysis

This executive summary is based on triangulation of peer-reviewed clinical trial evidence, regulatory milestones, guideline recommendations, public health data, and real-world registry findings relevant to left atrial appendage closure devices. Core evidence includes randomized LAAO trials, regulatory device authorizations, professional society atrial fibrillation guidelines, and epidemiologic data on atrial fibrillation prevalence, stroke risk, bleeding risk, and structural heart intervention pathways.

The assessment emphasizes verified themes over speculative forecasts: clinical eligibility, reimbursement readiness, regional healthcare infrastructure, device performance factors, imaging requirements, post-procedure surveillance, and the practical role of artificial intelligence. Insights were structured using industry terms such as left atrial appendage closure device, LAA occlusion, atrial fibrillation stroke prevention, structural heart intervention, percutaneous LAAO, nonvalvular atrial fibrillation, and anticoagulation alternative.

Conclusion: Evidence, Access, and Innovation Drive the Market

Left atrial appendage closure devices are becoming an increasingly important part of atrial fibrillation stroke prevention for patients who cannot safely rely on long-term anticoagulation. The market is supported by aging demographics, guideline recognition, expanding interventional expertise, stronger imaging workflows, and sustained demand for alternatives that balance stroke reduction with bleeding risk.

Future progress will depend on proven outcomes, reimbursement clarity, operator training, device innovation, registry-based monitoring, and responsible integration of artificial intelligence. Organizations that combine strong clinical evidence with scalable care pathways and region-specific access strategies will be best positioned in the global LAA closure device market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Left Atrial Appendage Closure Device Market, by Device Type
7.1. Introduction
7.2. Lariat
7.3. Watchman
8. Left Atrial Appendage Closure Device Market, by Procedure Type
8.1. Introduction
8.2. Percutaneous
8.3. Surgical
9. Left Atrial Appendage Closure Device Market, by Material Type
9.1. Introduction
9.2. Nitinol
9.2.1. Nickel Titanium Alloy
9.2.2. Superelastic Nitinol
9.3. Polymer Coated
10. Left Atrial Appendage Closure Device Market, by End User
10.1. Introduction
10.2. Cardiology Centers
10.3. Clinics
10.3.1. Ambulatory Care
10.3.2. Specialty Clinics
10.4. Hospitals
11. Left Atrial Appendage Closure Device Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online Channels
12. Left Atrial Appendage Closure Device Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Left Atrial Appendage Closure Device Market, by Group
13.1. NATO
13.2. G7
13.3. European Union
13.4. BRICS
13.5. ASEAN
13.6. GCC
14. Left Atrial Appendage Closure Device Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. Japan
14.5. India
14.6. United Kingdom
14.7. France
14.8. Canada
14.9. Italy
14.10. Australia
14.11. South Korea
14.12. Brazil
14.13. Mexico
14.14. Russia
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Acutus Medical, Inc.
16.3. Aegis Medical Group, Inc.
16.4. Angel Medical Systems, Inc.
16.5. Artio Medical, Inc.
16.6. AtriCure, Inc.
16.7. Boston Scientific Corporation
16.8. Cardia, Inc.
16.9. Cardiac Dimensions, Inc.
16.10. Conformal Medical, Inc.
16.11. EpiCardia Technologies, Inc.
16.12. FEops NV
16.13. InspireMD, Inc.
16.14. Keystone Heart Ltd.
16.15. Lepu Medical Technology Co., Ltd.
16.16. Lifetech Scientific Co., Ltd.
16.17. Medtronic plc
16.18. Nanjing YDB Technology Co., Ltd.
16.19. Occlufit Medical AG
16.20. Occlutech International AB
16.21. Sahajanand Medical Technologies Pvt. Ltd.
16.22. SentreHEART, Inc.
16.23. Shanghai Push Medical Device Technology Co., Ltd.
16.24. W. L. Gore & Associates, Inc.
List of Figures
FIGURE 1. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL LARIAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL LARIAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL LARIAT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL WATCHMAN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL WATCHMAN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL WATCHMAN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PERCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PERCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PERCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SURGICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SURGICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SURGICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL NITINOL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL NITINOL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL NITINOL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL NICKEL TITANIUM ALLOY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL NICKEL TITANIUM ALLOY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL NICKEL TITANIUM ALLOY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SUPERELASTIC NITINOL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SUPERELASTIC NITINOL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SUPERELASTIC NITINOL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL POLYMER COATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL POLYMER COATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL POLYMER COATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CARDIOLOGY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CARDIOLOGY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CARDIOLOGY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL AMBULATORY CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL AMBULATORY CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL AMBULATORY CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ONLINE CHANNELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ONLINE CHANNELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ONLINE CHANNELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 56. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 57. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 58. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 59. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 60. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 61. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 62. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 64. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 65. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 66. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 67. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 68. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 69. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 70. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 72. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 73. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 74. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 75. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 76. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 77. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 78. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 80. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 81. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 82. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 83. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 84. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 85. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 86. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 88. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 89. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 90. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 91. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 92. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 93. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 94. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 96. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 97. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 98. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 99. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 100. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 101. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 105. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 106. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 107. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 108. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 109. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 110. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 111. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 113. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 114. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 115. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 116. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 118. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 127. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 129. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 130. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 131. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 132. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 134. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 135. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 137. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 138. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 139. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 140. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 142. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 143. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 145. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 146. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 147. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 148. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 150. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 152. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 153. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 154. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 155. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 156. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 157. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 158. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 159. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 160. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 161. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 162. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 163. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 164. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 165. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 167. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 168. GERMANY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 169. GERMANY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 170. GERMANY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 171. GERMANY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 172. GERMANY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 173. GERMANY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. GERMANY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 175. GERMANY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 176. JAPAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 177. JAPAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 178. JAPAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 179. JAPAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 180. JAPAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 181. JAPAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. JAPAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 183. JAPAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 184. INDIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 185. INDIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 186. INDIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 187. INDIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 188. INDIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 189. INDIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. INDIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 191. INDIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 192. UNITED KINGDOM LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 193. UNITED KINGDOM LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 194. UNITED KINGDOM LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 195. UNITED KINGDOM LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 196. UNITED KINGDOM LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 197. UNITED KINGDOM LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. UNITED KINGDOM LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 199. UNITED KINGDOM LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 200. FRANCE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 201. FRANCE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 202. FRANCE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 203. FRANCE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 204. FRANCE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 205. FRANCE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. FRANCE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 207. FRANCE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 208. CANADA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 209. CANADA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 210. CANADA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 211. CANADA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 212. CANADA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 213. CANADA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. CANADA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 215. CANADA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 216. ITALY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 217. ITALY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 218. ITALY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 219. ITALY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 220. ITALY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 221. ITALY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. ITALY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 223. ITALY LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 224. AUSTRALIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. AUSTRALIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 226. AUSTRALIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 227. AUSTRALIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 228. AUSTRALIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 229. AUSTRALIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. AUSTRALIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 231. AUSTRALIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 232. SOUTH KOREA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 233. SOUTH KOREA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 234. SOUTH KOREA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 235. SOUTH KOREA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 236. SOUTH KOREA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 237. SOUTH KOREA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. SOUTH KOREA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 239. SOUTH KOREA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 240. BRAZIL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 241. BRAZIL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 242. BRAZIL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 243. BRAZIL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 244. BRAZIL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 245. BRAZIL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. BRAZIL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 247. BRAZIL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 248. MEXICO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. MEXICO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 250. MEXICO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 251. MEXICO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 252. MEXICO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 253. MEXICO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. MEXICO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 255. MEXICO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. RUSSIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 258. RUSSIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 259. RUSSIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 260. RUSSIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 261. RUSSIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. RUSSIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 263. RUSSIA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 264. SPAIN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 265. SPAIN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 266. SPAIN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 267. SPAIN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 268. SPAIN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2017-2032 (USD MILLION)
TABLE 269. SPAIN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. SPAIN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 271. SPAIN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 272. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 273. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Acutus Medical, Inc.
  • Aegis Medical Group, Inc.
  • Angel Medical Systems, Inc.
  • Artio Medical, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardia, Inc.
  • Cardiac Dimensions, Inc.
  • Conformal Medical, Inc.
  • EpiCardia Technologies, Inc.
  • FEops NV
  • InspireMD, Inc.
  • Keystone Heart Ltd.
  • Lepu Medical Technology Co., Ltd.
  • Lifetech Scientific Co., Ltd.
  • Medtronic plc
  • Nanjing YDB Technology Co., Ltd.
  • Occlufit Medical AG
  • Occlutech International AB
  • Sahajanand Medical Technologies Pvt. Ltd.
  • SentreHEART, Inc.
  • Shanghai Push Medical Device Technology Co., Ltd.
  • W. L. Gore & Associates, Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.04 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.78 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Heart Defect Closure Devices - Global Strategic Business Report - Product Image

Heart Defect Closure Devices - Global Strategic Business Report

  • Report
  • 177 Pages
  • Global
From
Left Atrial Appendage (LAA) Closure Devices - Global Strategic Business Report - Product Image

Left Atrial Appendage (LAA) Closure Devices - Global Strategic Business Report

  • Report
  • 286 Pages
  • Global
From
Left Atrial Appendage Closure Device Market Report 2026 - Product Image

Left Atrial Appendage Closure Device Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Left Atrial Appendage Closure Devices Market Report by Product, End User, and Region 2026-2034 - Product Image

Left Atrial Appendage Closure Devices Market Report by Product, End User, and Region 2026-2034

  • Report
  • 144 Pages
  • Global
From
Left Atrial Appendage Closure Device Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Left Atrial Appendage Closure Device Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Left Atrial Appendage Closure Device Market

The Left Atrial Appendage Closure Device (LAACD) is a medical device used to reduce the risk of stroke in patients with atrial fibrillation. It is a minimally invasive procedure that involves the placement of a device in the left atrial appendage, a small pouch in the heart, to prevent blood clots from forming and entering the bloodstream. The device is designed to reduce the risk of stroke without the need for long-term anticoagulation therapy. The LAACD market is a rapidly growing segment of the cardiovascular device market. It is estimated that the LAACD market will continue to grow due to the increasing prevalence of atrial fibrillation and the need for stroke prevention. The market is expected to benefit from technological advancements, such as the development of new devices and improved delivery systems. Some of the major players in the LAACD market include Abbott, Boston Scientific, Medtronic, and St. Jude Medical. These companies are actively developing and marketing LAACD devices to meet the needs of patients with atrial fibrillation. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.